Treadwell Therapeutics scores $27 mln seed
Treadwell Therapeutics, a clinical-stage oncology company, has secured $27 million in seed funding.
Treadwell Therapeutics, a clinical-stage oncology company, has secured $27 million in seed funding.
Copyright PEI Media
Not for publication, email or dissemination